StemcellX

Endre Kiss-Toth

Budapest Zoo Gorilla First to Receive Stem Cell Arthritis Treatment

Budapest Zoo Gorilla First to Receive Stem Cell Arthritis Treatment Liesel, the elderly matriarch in Budapest Zoo, has been finding it difficult to walk on her left leg for a while, suggesting she may suffer from osteoarthritis.    A team led by Endre Sos (Chief Vet and Acting Director General at the Budapest Zoo) and […]

Budapest Zoo Gorilla First to Receive Stem Cell Arthritis Treatment Read More »

StemCellX partners with Budapest Zoo and Botanical Garden, to develop treatments for exotic animals.

StemCellX, a regenerative medicine company, today announced a partnership agreement with Budapest Zoo and Botanical Garden, one of the most visited zoos in Europe, to develop allogeneic stem cell treatments for exotic animals. The partnership will enable Budapest Zoo and Botanical Gardens to benefit from state-of-the-art treatments to improve the quality of life for a

StemCellX partners with Budapest Zoo and Botanical Garden, to develop treatments for exotic animals. Read More »

#Sciencebehind – 4: Canine Oesteoarthritis

Canine osteoarthritis is a common chronic degenerative joint condition that affects the whole joint but the most prominent symptom is the loss of articulate cartilage. OA causes pain, lameness, decreased mobility, and if not managed on time and correctly the symptoms will escalate to muscular atrophy, joint effusion, incorrect joint articulation, etc. Dogs that experience

#Sciencebehind – 4: Canine Oesteoarthritis Read More »

Use of mesenchymal stem cells (MSCs) in regenerative medicine

According to recent studies from our own research group as well as others, mesenchymal stem cells can be used for various purposes from aiding in wound healing to restoring crucial organ functions (pancreatic islet cells for diabetes patients). A possibility to treat orthopaedic disorders by stem cell therapy has received a lot of attention in

Use of mesenchymal stem cells (MSCs) in regenerative medicine Read More »

StemCellX Breaks ground on a new R&D and a GMP Stem Cell Production Site

StemCellX will soon have a new R&D and a GMP Production Site: We will occupy over 1000 square metres within this new, state-of-the-art laboratory building, scheduled to be completed by Q3 2022. Our facility will accommodate advanced GMP manufacturing suites for large-scale, commercial production of our stem cell-based products, as well as R&D laboratories. We have

StemCellX Breaks ground on a new R&D and a GMP Stem Cell Production Site Read More »